BCL2 and Norrie disease: Furthermore, IGF-1 treatment inhibited apoptosis in ND models by inactivating the apoptosis pathway, such as increasing the activity of NF-kB, expression of BCL2, or inhibiting caspase activity [230,284,287,290,292,294,295].